Syneos Health Signs Agreement with Taipei Medical University Hospital to Support Clinical Trials in Taiwan
February 13, 2024
MORRISVILLE, N.C. – February 13, 2024 – Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, has signed an agreement with Taipei Medical University Hospital (TMUH). The agreement expands the Company’s clinical trial capabilities across a broad range of therapeutic areas in Taiwan.
TMUH now becomes part of the Syneos Health Catalyst and Site Network Partnerships program, including 110+ clinical sites and 60+ commercial site networks. As part of the Site Network Partnerships program, TMUH joins a select set of high-performing investigative site networks strategically aligned to Syneos Health’s clinical studies. Site Network Partnerships provide enhanced patient access, improved efficiencies, specialized expertise and access to diverse patient populations across all therapeutic areas and phases.
“Our venture with TMUH is part of Syneos Health’s global strategy to accelerate our clinical development impact in this rapidly growing and changing market,“ said Dr. Ken J. Lee, General Manager and Regional Head, Clinical Development, APAC, Syneos Health. “This collaboration supports our strong focus on customers, achieving consistent delivery and quality for their programs, and executing fit-for-purpose solutions that address their unique and complex needs.”
“As clinical trials are the most critical stage of new drug development, TMUH is proud to be the first cross therapeutic area collaboration site in Taiwan to join the Syneos Health Catalyst and Site Network Partnership program to help advance clinical trials around the world,” said Dean Shi Chun Ming, superintendent of TMUH. “Through this collaboration, we hope to expand our participation in international clinical trials as we strive to become the preferred partner for domestic and foreign biotech pharmaceutical companies.”
About Syneos Health
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.
We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics.
Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.
Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.
To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com.
